Back to Journals » OncoTargets and Therapy » Volume 8

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]

Total article views   HTML views PDF downloads Totals
8,269 Dovepress* 7,885+ 1,569 9,454
PubMed Central* 384 142 526
Totals 8,269 1,711 9,980
*Since 9 March 2015
+Since July 2016

View citations on PubMed and Google Scholar